Delivery Order SPE2DR25D3012-SPE2DR26F4C8W
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for Act-O-Vials on November 18, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $9,465.42 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with completion expected by October 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The company will perform the work from its Corporate Office...
- The Defense Logistics Agency awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for ACT-O-VIALS on November 25, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $10,626.56 to AmerisourceBergen Drug Corp for Act-O-Vials, with a completion deadline of November 17, 2025. This is a firm fixed price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive procurement to supply this medical product to support federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $11,348.20 to AmerisourceBergen Drug Corp on December 4, 2025, for Act-O-Vials medical supplies. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is set to complete by December 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $20,986.24 delivery order contract to AmerisourceBergen Drug Corp for Act-O-Vials on October 29, 2025, with completion expected by October 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $19,924.80 to AmerisourceBergen Drug Corp for Act-O-Vials on November 12, 2025, with completion expected by November 13, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a...
- The Defense Logistics Agency awarded a delivery order valued at $6,641.60 to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,328.32 to AmerisourceBergen Drug Corp for Act-O-Vials, a pharmaceutical delivery system product. This competitive award, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, was made under a firm fixed-price contract type with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $10,493.72 to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order under its...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4C8WDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for Act-O-Vials on December 4, 2025, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is fulfilling this order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle that extends through December 2026. Act-O-Vials are specialized medical vial delivery systems used across military and federal healthcare supply chains. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role in supplying pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded delivery orders reflects its established capability to meet federal procurement requirements and support military medical logistics worldwide through the DLA's comprehensive pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 12/3/25 |